EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H24N2O7S |
| Net Charge | 0 |
| Average Mass | 460.508 |
| Monoisotopic Mass | 460.13042 |
| SMILES | CCOc1cc([C@@H](CS(C)(=O)=O)N2C(=O)c3cccc(NC(C)=O)c3C2=O)ccc1OC |
| InChI | InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1 |
| InChIKey | IMOZEMNVLZVGJZ-QGZVFWFLSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antiviral agent A substance that destroys or inhibits replication of viruses. phosphodiesterase IV inhibitor An EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor that specifically blocks the action of phosphodiesterase IV. |
| Applications: | antirheumatic drug A drug used to treat rheumatoid arthritis. dermatologic drug A drug used to treat or prevent skin disorders or for the routine care of skin. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. non-steroidal anti-inflammatory drug An anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. antipsoriatic A drug used to treat psoriasis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| apremilast (CHEBI:78540) has role anti-ulcer drug (CHEBI:49201) |
| apremilast (CHEBI:78540) has role antimicrobial agent (CHEBI:33281) |
| apremilast (CHEBI:78540) has role antipsoriatic (CHEBI:50748) |
| apremilast (CHEBI:78540) has role antirheumatic drug (CHEBI:35842) |
| apremilast (CHEBI:78540) has role antiviral agent (CHEBI:22587) |
| apremilast (CHEBI:78540) has role dermatologic drug (CHEBI:50177) |
| apremilast (CHEBI:78540) has role gout suppressant (CHEBI:35845) |
| apremilast (CHEBI:78540) has role non-steroidal anti-inflammatory drug (CHEBI:35475) |
| apremilast (CHEBI:78540) has role ophthalmology drug (CHEBI:66981) |
| apremilast (CHEBI:78540) has role phosphodiesterase IV inhibitor (CHEBI:68844) |
| apremilast (CHEBI:78540) is a N-acetylarylamine (CHEBI:13790) |
| apremilast (CHEBI:78540) is a aromatic ether (CHEBI:35618) |
| apremilast (CHEBI:78540) is a phthalimides (CHEBI:82851) |
| apremilast (CHEBI:78540) is a sulfone (CHEBI:35850) |
| IUPAC Name |
|---|
| N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide |
| INNs | Source |
|---|---|
| apremilast | WHO MedNet |
| apremilast | ChemIDplus |
| aprémilast | WHO MedNet |
| apremilastum | WHO MedNet |
| Synonyms | Source |
|---|---|
| CC 10004 | ChemIDplus |
| CC-10004 | ChemIDplus |
| CC10004 | ChemIDplus |
| Brand Names | Source |
|---|---|
| Apremilast accord | ChEMBL |
| OTEZLA | KEGG DRUG |
| Manual Xrefs | Databases |
|---|---|
| 4829 | DrugCentral |
| Apremilast | Wikipedia |
| D08860 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Reaxys:12446985 | Reaxys |
| CAS:608141-41-9 | KEGG DRUG |
| CAS:608141-41-9 | ChemIDplus |
| Citations |
|---|